Related references
Note: Only part of the references are listed.In Vitro Mechanistic Study of the Distribution of Lascufloxacin into Epithelial Lining Fluid
Kouhei Ohya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions
Mika Murata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers
Hidetoshi Furuie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group
Yuka Yamagishi et al.
ANAEROBE (2018)
In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977)
Ryuta Kishii et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Bacteriological Assessment of Healthcare-Associated Pneumonia Using a Clone Library Analysis
Shingo Noguchi et al.
PLOS ONE (2015)
Significance of Anaerobes and Oral Bacteria in Community-Acquired Pneumonia
Kei Yamasaki et al.
PLOS ONE (2013)
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid
Sungmin Kiem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Share Paper
